Immunosuppressive Treatment and the Risk of Diabetes in Rheumatoid Arthritis

PLoS ONE - United States
doi 10.1371/journal.pone.0210459
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Hydroxychloroquine and Risk of Diabetes in Patients With Rheumatoid Arthritis

JAMA - Journal of the American Medical Association
Medicine
2007English

Risk of Diabetes Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

Is Rheumatoid Arthritis a Cardiovascular Risk Equivalent to Diabetes?

Arthritis Care and Research
Rheumatology
2018English

The Treatment of Rheumatoid Arthritis.

JAMA - Journal of the American Medical Association
Medicine
1929English

Treatment of Rheumatoid Arthritis

Rheumatology
RheumatologyPharmacology
1997English

Treatment of Rheumatoid Arthritis

1981English

Penicillamine in the Treatment of Rheumatoid Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1972English

Pregnenolone in the Treatment of Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1951English

Proseptasine in the Treatment of Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1953English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy